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Identification of leukaemic cells in bone marrow and blood samples by a
new cytofluorometric assay
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Summary The expression of thymidine kinase - an enzyme of the DNA precursor pathway - is strictly
regulated during the normal cellular cycle, but is much higher and permanently expressed in malignant growing
cells. We used this fact to detect neoplastic cells in samples freshly taken from leukaemia patients and kept
frozen in liquid nitrogen until analysis. Using a new cytofluorometric assay for thymidine kinase in single cells,
we were able to identify leukaemic cells in a surplus of normal ones. Our results demonstrate the benefits of
this assay for leukaemia diagnosis.
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Thymidine kinase (TK) catalyses the ATP-dependent
phosphorylation of thymidine and deoxyuridine. The activity
of TK is strictly regulated during the normal cell cycle,
peaking at the onset of DNA synthesis but remaining
extremely low in resting cells (Bello, 1974; Wawra et al.,
1981). In the past, we have established a cytofluorometric
method based on the uptake of a fluorescent nucleoside that
is subsequently phosphorylated by the cells in the same
manner as thymidine (Hengstschlager and Wawra, 1993a).
The intracellular accumulation of this fluorescence, when
determined by a flow cytometer, is an indication of the TK
activity per every single cell.
We have already shown that normal cells express their TK
gene during a limited period in early S-phase, whereas in
abnormally growing cells continuous transcription causes a
much higher steady-state concentration of TK mRNA and
therefore a much higher activity of the enzyme (Hengsts-
chlager et al., 1994a). When applied to cells in culture, our
new cytofluorometric assay allows us to discriminate between
normal growing cells, like diploid fibroblasts, and virally
transformed cells or lines derived from tumours (Hengsts-
chlager et al., 1994b). Moreover, this method enabled us to
identify a few transformed cells mixed with a 10 000-fold
excess of normal ones (Hengstschlager and Wawra, 1993b).
The benefits of such a simple and general tumour marker are
obvious, but it may be argued that cells in culture often
collect mutations and adaptations, which gives a selective
advantage in culture, but does not reflect the in vivo situation.
This poses the question whether the observed phenomenon is
a general effect of malignant growth or merely a secondary
event arising during the establishment of a cell line. To
answer this question, we analysed material, either blood or
bone marrow, taken directly from patients with different
leukaemias.
Materials and methods
Cells
Samples from patients suffering from acute lymphocytic
leukaemia (ALL) or acute myelogeneous leukaemia (AML)
were taken at the time of diagnosis. Human leucocytes were
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isolated from heparinised peripheral blood of leukaemia
patients and from two normal subjects using the Ficoll-
Hypaque gradient method. After washing three times in
phosphate-buffered saline (PBS), the leucocytes were resus-
pended in RPMI-1640 medium containing 20% human AB
plasma and 10% dimethylsulphoxide. Cells were slowly
cooled to -70°C and then stored in liquid nitrogen. In
addition, normal lymphocytes were stimulated with 5 pg
phytohaemagglutinin per ml of medium for about two cell
doubling times (40 h). Buffy coat, obtained by leukapheresis,
stimulated lymphocytes, and bone marrow samples from
patients were treated and frozen as described above.
Non-stimulated leucocytes from leukaemia patients and
normal controls, phytohaemagglutinin-stimulated normal
lymphocytes and bone marrow cells were all thawed as fast
as possible in a 37°C water bath and transferred into 5 ml of
RPMI-1640 medium containing 20% fetal calf serum. After
30 min, cells were washed with RPMI-1640 medium without
serum and incubated with the fluorescent thymidine analogue
as described below. For analysis, we used between 106 and
107 cells per sample.
Determination of intracellular TK activity simultaneously with
DNA distribution
Synthesis and purification of the fluorescent thymidine
analogue N-dansyl-amino-uracil-deoxyriboside (DAUdR,
formerly called AUdR/DANS) have been published pre-
viously, and cytofluorometric measurement of TK activity in
living cells has also generally been performed as described
(Hengstschlager and Wawra, 1993a). We just added some
minor revisions at the DNA staining part of the procedure
mainly to improve the resolution of DNA analysis. Cells were
exposed in RPMI-1640 medium without serum for 30 min to
1.5 pM DAUdR (a stock solution was prepared in 70%
ethanol) at 37°C and 7.5% carbon dioxide. After harvesting
by centrifugation for 5 min at 1000 r.p.m., cells were washed
twice with PBS. The cells were resuspended in 100 mM Tris
HCl (pH 7.4), 154 mM sodium chloride, 1 mM calcium
chloride, 0.5 mm magnesium chloride, 0.1% NP-40 and
0.2% bovine serum albumin (BSA) (a 10 x stock solution of
BSA was stored at -20°C and was thawed briefly before
analysis) to a concentration of about 1 x 106 cells ml-'. DNA
staining was performed with 1.5 pg ml-' ethidium bromide
for 10-20 min on ice. Cells were analysed within the
following 20 min to ensure that they were still alive and
that the phosphorylated thymidine analogue was not washed
out.
The fluorescences reflecting TK activity and DNA content
were simultaneously measured with a Partec PAS-I1 flow
cytometer. Excitation was UV light (< 380 nm) for bothFlow cytometry ofleukaemic cells
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dyes; filters were set to obtain a complete separation of
emission of the fluorescent analogue (500 nm) and of
ethidium bromide (605 nm).
Results
In order to show how our results have to be interpreted, the
result of a typical analysis (bone marrow) is shown in Figure 1.
In order to determine the amount of DNA in the presence of
DAUdR (reflecting TK activity), living cells had to be stained
with ethidium bromide. This does not yield the clear pattern of
DNA distribution normally obtained with DAPI or Hoechst in
DNA content >
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Figure 1 Schematic presentation of the results of a cytofluoro-
metric measurement. Top, distribution of DNA content during
the analysed population. Bottom, two-dimensional presentation
of DNA content (abscissa) against thymidine kinase (TK) activity
(ordinate, note that increasing enzyme activity goes down the
axis!). The arrays labelled G1, S and G2 reflect normally growing
cells in their different stages of cell cycle; the area where
malignant cells appear is separately indicated.
fixedcells, but it plainly allows identification ofGI-, S- and G2-
phase cells. The presented DNA distribution represents a
mixture of different populations of bone marrow cells: resting
GO cells, normally growing cells and malignant ones.
The two-dimensional presentation (Figure 1) shows
simultaneous measurement of two fluorescences, reflecting
DNA amount and TK activity for each cell. Normally
growing cells have low TK activity in G,, this activity
increases during early S-phase and returns to about the
original level in G2. Resting (GO) cells, like unstimulated
lymphocytes, have even lower TK activity. Therefore, many
GO cells are below the detection limit for TK and can
therefore not be seen in the two-dimensional pattern
(compare samples 5 and 10 in Figure 2). Malignant growing
cells always exhibit more TK activity than S-phases of
normal cells do. These cells are therefore found in another
area of the diagram (Figure 1). So, in cases where we find a
separated population of cells with high TK content, we can
identify these as malignant cells.
This was found in the samples 2-4, 6-9 and 12 -14
(Table I and Figure 2), although in sample number 12 it was
not that obvious. In the two remaining samples, 1 and 11
(and also in 12), the areas of normal and neoplastic cells
overlap, although the area representing malignant cells is
densely populated (compare with control samples 5, 10 and
15). Such samples are also strongly positive, but for a safe
diagnosis a reference sample (like 5) should have been run
simultaneously to ensure that no type of artefact causes the
high TK values.
In an earlier report, we analysed artificial mixtures of
growing normal and malignant cells and were able to identify
tumour cells mixed with a 10 000-fold excess of normal ones
(Hengstschlager and Wawra, 1993b). From the data in the
present study, we may conclude that a total of at least some
50 or 100 malignant cells are necessary for identification
under average conditions. Therefore, the ratio of normal vs
neoplastic cells is not critical: 104- 106 cells can easily be
analysed in a normal sample so that the limit of, say, 100
malignant cells may be reached even when these cells are
extremely sparse.
It is important to emphasise that intracellular TK activity
is not a diagnostic marker for the forms of leukaemia listed
in Table I, but is a general indicator for malignant growth.
Discussion
One of the major demands in tumour biology is a cheap and
robust diagnostic tool for the detection of tumour cells (Hall
et al., 1994). We expect our method to provide such a tool as
it is easy to use and applicable to hospitals and clinics
without sophisticated molecular biology laboratories. In our
Table I Identification of the samples presented in Figure 2
Diagnosis Sex Sample Blast cells (%) Result No. (Figure 2)
AML/FAB MO M BM 90 + I
ALL/FAB L2 F BC 50 + + 2
ALL/FAB L3 M BM 60 + + 3
PB 38 + + 4
AML/FAB M2 M BC 90 + + 6
PB 50 + + 7
AML/FAB M2 M BM 83 + + 8
Plasma cell leukaemia F PB 28 + + 9
AML/FAB M3 F BM 75 + 11
PB 82 + 12
AML/FAB M2/4 F BC 90 + + 13
PB 90 + + 14
Normal M Stimulated lymphocytes - Negative 5
Unstimulated lymphocytes Negative 10
Normal M Unstimulated lymphocytes Negative 15
+,positiveidentification ofmalignantcells withinthispopulation. + +, positive identification would be possibleevenintheabsence ofanegative
control sample. The percentage values for blast cells are obtained from visual examination before freezing. BM, bone marrow; BC, buffy coat; PB,
peripheral blood.Flow cytometry of leukaemic cells
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Figure 2 Cytofluorometric measurement of thymidine kinase in different forms of leukaemia (see Figure 1 for explanation of
graphs). Blood cells and/or bone marrow from different patients with different leukaemias were compared with normal control
blood (extreme right position in each row). See Table 1 for the identification of samples.
previous publications, we have demonstrated the application
of this assay on a wide variety of transformed or tumour-
derived cell lines. However, it may always be argued that,
during the artificial passages in culture, the cells accumulate
modifications and artefacts that do not mirror the native
situation. Here we present the first in vivo studies, showing
that this method is very effective for biopsy material.
The method seems useful for discrimination between
leukaemic and normal cells to get a first, fast diagnosis.
Clearly, additional morphological, cytogenetic and perhaps
molecular genetic studies are necessary to define subtypes in
regard to diagnosis and therapeutic procedures. Further, our
new test is most promising for the detection of residual
malignant cells after leukaemia chemotherapy. The morpho-
logical methods that are presently used fail to detect fewer
than 1% blasts in peripheral blood, and complete remission is
assumed if fewer than 5% of blasts are found in bone
marrow. There have been many attempts to reduce these
levels by cytogenetic techniques, by in situ hybridisation, by
polymerase chain reactions, etc. but all these techniques raise
serious disadvantages (see Campana and Pui, 1995 for a
review). Methods using molecular biology are extremely
sensitive, but are specific for a certain type of leukaemia or
even for a certain patient, whereas our test is obviously
universally applicable. With this method, we can find a few
malignant cells in relatively large populations (up to a total
of 106 cells) so that we can detect minimal residual disease
levels of 1 in 10 000. If done with fresh material, the whole
procedure from the first addition of the dye until the final
diagnosis, might be performed within 3 h, even if a few
different samples are prepared simultaneously. In this
context, we want to emphasise that this method should
work with all types of flow cytometric instruments provided
that the excitation is done with UV light (300-350 nm). Any
UV lamp or UV laser will be sufficient, but not the most
common argon ion laser (488 nm excitation).
In the case of morphological screening of bone marrow, a
few malignant cells may be hidden by the amount of normal
precursor cells that are always present. We have every reason
to believe that we see only the malignant blasts in the
fluorescence pattern. Recently we found that in a tumour
progression model, only the later and malignant stages wereFlow cytometry of leukaemic cells
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positive in our assay, whereas the first biopsy containing
benign tumour cells looked normal (Hengstschlager et al.,
1996).
But why is TK content an indicator of malignancy in so
many different types of leukaemia? Elevated levels of
thymidine kinase were found many times in serum from
patients with malignant diseases. Enzymes involved in purine
metabolism show normal or reduced activity in tumours
when compared with normal cells, but thymidylate synthase,
connected with the de novo pathway of deoxynucleotides, was
found to increase with tumour progression (Bardot et al.,
1994). We have shown already that thymidine kinase also
increases with tumour progression (Hengstschlager et al.,
1996) and that the change in regulation of TK activity during
the cell cycle is accompanied by a similar change in TK
mRNA steady-state levels (Hengstschlager et al., 1994a).
Obviously, activity of TK is dominated by the amount of its
mRNA, and the difference between normal and malignant
cells is at the level of transcription or shortly thereafter. But
the TK gene is one of a family of S-phase-regulated genes
which share common properties in respect to their promoters.
DNA polymerase a, dihydrofolate reductase and thymidylate
synthase are other members and all are regulated by the
transcription factor E2F, which itself is regulated by the
retinoblastoma gene product (pRb) (Nevins, 1992). This pRb
is a target for the tumour antigens of DNA tumour viruses
(Ogris et al., 1993; Mudrak et al., 1994), so that in virus-
transformed cells, pRb allows E2F to activate these genes.
Recently, we have shown that the mRNA levels of both
subunits of ribonucleotide reductase and of dihydrofolate
reductase, but not of deoxycytidine kinase, mirror exactly the
regulation of TK mRNA during the cell cycle of normal and
transformed cells (Hengstschlager et al., 1994c).
But pRb is cell cycle-regulated by the cyclin system [see
Sieff (1994) for a review], and this is known to be a target for
two of the most prominent tumour suppressor gene products,
p16 and p53 (Peters, 1994). p16 is an inhibitor of the cyclin
D/cdk4 kinase (Serrano et al., 1993), p53 is an activator of
p21 which inhibits cyclin D/cdk2 and cyclin E/cdk2 (Waga et
al., 1994). Therefore, the described loss of enzymatic
regulation is an indicator for many different tumour-causing
mechanisms: presence of viral coded tumour antigen
(Hengstschlager et al., 1994a); defect in pRb (Horwitz et
al., 1990) (see Hengstschlager et al., 1994b for an example),
and defect in either p53, p21 or p16. This explains why all
our examined leukaemia samples are sensitive to this test.
Compared with other S-phase-regulated genes, TK
appears to be the most convenient indicator for this effect:
the half-life of the enzyme is short enough to reflect
variations during the cell cycle; there is no further regulation
on protein level; and TK activity is easy to detect on a
cellular level with our new assay. Our results demonstrate
that samples from patients are as suitable for this
identification as cultivated cells. This opens the possibility
of using this method widely for a preliminary clinical
diagnosis and especially for detection of minimal residual
disease during leukaemia therapy.
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